Molecular testing results as a quality metric for evaluating cytopathologists' utilization of the atypia of undetermined significance category for thyroid nodule fine-needle aspirations.

VanderLaan, Paul A; Nishino, Michiya

VanderLaan, Paul A; Nishino, Michiya.

Afiliación

VanderLaan PA; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. Electronic address: pvanderl@bidmc.harvard.edu.
Nishino M; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

J Am Soc Cytopathol ; 11(2): 67-73, 2022.

Article en En | MEDLINE | ID: mdl-34756586

Asunto(s)

Nódulo Tiroideo; Biopsia con Aguja Fina; Humanos; Técnicas de Diagnóstico Molecular; Estudios Retrospectivos; Nódulo Tiroideo/diagnóstico; Nódulo Tiroideo/genética

Palabras clave

Afirma genomic sequencing classifier (GSC); Atypia of undetermined significance (AUS); Bethesda System for Reporting Thyroid Cytopathology; Molecular testing; Quality improvement; Thyroid

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Nódulo Tiroideo Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Revista: J Am Soc Cytopathol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google